Skip to content
Brand AI

Direct Biologics, LLC

Recent events

Recent events tied to this brand in public sources.

Back to profile1 entries

  1. 2020

    Direct Biologics to use Bioclinica IRT in COVID-19 study

    Bioclinica announced that Direct Biologics would use Bioclinica's Interactive Response Technology for the EXIT COVID-19 study, a multicenter FDA phase II clinical trial of ExoFlo for COVID-19 acute respiratory distress syndrome.

    Source